Navigation Links
Peregrine Pharmaceuticals Adds Noted Oncologist Dr. Bruce Chabner as Clinical Advisor to Support Advancement of Its Clinical Programs
Date:8/31/2009

TUSTIN, Calif., Aug. 31 /PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM), today announced that noted cancer researcher Bruce Chabner, M.D., will serve as a clinical advisor to the company on the design of clinical trials for the bavituximab cancer program. Dr. Chabner is currently the clinical director of Massachusetts General Hospital (MGH) Cancer Center, chief of hematology and oncology at MGH and a professor of medicine at Harvard Medical School. Before coming to MGH, Dr. Chabner had a distinguished 25-year career at the National Cancer Institute (NCI), including serving as scientific director and director of the Division of Cancer Treatment. He has received numerous honors and awards, including the U.S. Public Health Service's Distinguished Service Award for his leadership in the development and approval of paclitaxel (Taxol(R)), a mainstay of current cancer therapy.

Dr. Chabner joins a group of advisors that have been assisting Peregrine in planning for the next stage of clinical trials for its bavituximab and Cotara(R) cancer programs. Bavituximab is currently being evaluated in three Phase II clinical trials in patients with advanced breast and lung cancer. Encouraging preliminary data from ongoing bavituximab clinical trials was presented at the 2009 Annual Meeting of the American Society of Clinical Oncology.

"Bavituximab's novel mechanism that enables the patient's immune system to attack tumors more effectively combined with its natural synergy with chemotherapy make it an intriguing and promising new approach to treating solid tumors," said Dr. Chabner. "The early clinical data on bavituximab is encouraging and I look forward to assisting Peregrine as they advance the bavituximab cancer program into late
'/>"/>

SOURCE Peregrine Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. NIAID Awards New Grant to Expand Studies of Peregrines Anti-PS Antibodies to Treat Viral Hemorrhagic Fevers
2. Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2009
3. Peregrine Pharmaceuticals Completes Planned Patient Enrollment in Bavituximab Phase I Cancer Trial
4. Peregrine Pharmaceuticals Awarded Broad New U.S. Patent for Vascular Imaging Applications of Its PS-Targeting Platform
5. ASCO Research Foundation Grant Will Support Study of Peregrines Bavituximab in Lung Cancer
6. Peregrine Pharmaceuticals Reports Progress in Cotara(R) Brain Cancer Clinical Program
7. Peregrine Pharmaceuticals Receives Additional Time to Regain Compliance With NASDAQs Minimum Bid Price Rule
8. Peregrine Pharmaceuticals to Report Third Quarter FY 2009 Financial Results
9. Peregrine Pharmaceuticals Bavituximab Achieves Primary Endpoint in First Stage of Phase II Breast Cancer Study
10. Peregrine Pharmaceuticals Reports Financial Results for the Second Quarter of Fiscal Year 2009
11. Peregrine Pharmaceuticals Awarded Broad New U.S. Patent for Anti-Viral Applications of Phospholipid-Targeting Antibodies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/31/2014)... Santa Barbara, CA (PRWEB) October 31, 2014 ... for holiday shoppers to find affordable but tasteful gifts for ... special 22nd Annual Early Bird Gift Giving Special , ... percent off when they purchase Wine Club Gift membership. ... to take advantage of this special. Besides offering discounts, Gold ...
(Date:10/31/2014)... Miami Beach, Florida (PRWEB) October 31, 2014 ... Hydroponics” or, the “Company”) today announced it has signed ... three Canada-based companies in the urban cultivation sector - ... Ltd. (BC Northern Lights”), and W3 Metal Inc. (“W3 ... Lights, the “Target Companies”). Pursuant to the LOI ...
(Date:10/31/2014)... NY (PRWEB) October 31, 2014 ... the most remarkable gifts of life — building a ... matching extraordinary surrogate mothers and donors with hopeful intended ... in unforeseen circumstances. , It’s a collective aptitude of ... agencies, surrogacy lawyers, and fertility clinics that help provide ...
(Date:10/31/2014)... 31, 2014 Phoenix dentist , Dr. ... for November. Whether patients simply need routine care or have ... time than now to get that necessary care. The right ... off routine and even essential treatments due to financial concerns. ... savings on any treatments offered by the team at Christy ...
(Date:10/31/2014)... (PRWEB) October 31, 2014 Radiology ... see very little difference between diagnostic imaging centers ... of Marketing for DigitalOne. “Differentiation is critical ... in Radiology when you consider the intense competition ... Imaging of Salem will stand-out from the competition ...
Breaking Medicine News(10 mins):Health News:Gold Medal Wine Club now offering Early Bird Gift Giving Special for Holidays 2Health News:Urban Hydroponics Inc. Signs Definitive Agreement to Merge with Canadian Hydroponics Companies 2Health News:Urban Hydroponics Inc. Signs Definitive Agreement to Merge with Canadian Hydroponics Companies 3Health News:Urban Hydroponics Inc. Signs Definitive Agreement to Merge with Canadian Hydroponics Companies 4Health News:Urban Hydroponics Inc. Signs Definitive Agreement to Merge with Canadian Hydroponics Companies 5Health News:Over 800 New Surrogate Mother Members at FindSurrogateMother.com Helping Create Pathways to Parenthood 2Health News:Over 800 New Surrogate Mother Members at FindSurrogateMother.com Helping Create Pathways to Parenthood 3Health News:Phoenix Dentist, Dr. Christy, is Now Offering Ten Percent Off On All Dental Treatments for the Month of November 2Health News:Diagnostic Imaging of Salem Expects Growth Partnering with DigitalOne 2
... the relationship between use of antidepressants and level ... the link between depression and level of alcohol ... Addiction and Mental Health (CAMH) concluded that women ... who did not experience depression, regardless of antidepressant ...
... conducted in eight hospitals in Peru concludes that opening ... lowers the risk of airborne contagion//. ,The ... than double that of mechanically ventilated negative-pressure rooms and ... closed. ,The researchers, led by Rod Escombe ...
... can effectively eliminate rabies in dogs//., ,The vaccine, ... developed by scientists at the High Security Animal Disease Laboratory ... capsule attracts stray dogs due to its artificial taste enhancers ... it. Once inside the dog's mouth, the capsule bursts and ...
... that single-slice magnetic resonance imaging (MRI) is a fast ... ,Excessive intra-abdominal fat is known to be a major ... illnesses in children and teenagers. , Unlike ... forming skin folds or "love handles," internal fat located ...
... should be brought into close physical contact with their ... Germany's Professional Association of Paediatricians (BVKJ) here. ... rate of development, grow faster and suffer less brain ... said spokesman Thomas Fendel. ,The hearts and ...
... An Indian American fitness guru has created a fusion of ... in the United States//. , ,Sarina Jain, also ... Bhangra' and is credited with the introduction of Bhangra, the ... ,Jain holds her aerobic classes all over the US, ...
Cached Medicine News:Health News:Antidepressants Help Men Decrease Alcohol Consumption, but Not Women 2Health News:Airborne Infection Less in Naturally Ventilated Rooms 2Health News:Single Slice MRI- Handy Tool to Identify Children at Risk 2
(Date:10/31/2014)... -- Digirad Corporation (Nasdaq: DRAD) today announced that it has sent ... ), a healthcare commercialization services company, responding to PDI,s ... Digirad calls upon PDI to immediately ... operate in the ordinary course of business and to ... on acquisitions or other extraordinary transactions. Digirad believes that ...
(Date:10/31/2014)... Oct. 31, 2014  Grammy Award-winner Bruce Hornsby ... audience of philanthropists, athletes, actors, and musicians during the ... November 19 at the Mandarin Oriental Hotel in ... event will honor six individuals who embody the values ... will bestow its highest honor, the Spirit of an ...
(Date:10/31/2014)... -- Australian biopharmaceutical company Specialised Therapeutics Australia (STA) is pleased ... combination with gemcitabine, will be reimbursed via the Pharmaceutical ... from 1 November. In ... most common cause of cancer mortality. Pancreatic cancer ... lowest 5-year survival of all common cancers at 5.2%. ...
Breaking Medicine Technology:Digirad Delivers Letter To PDI, Inc. Responding To PDI's Summary Rejection Of Digirad's Offer To Acquire Company 2Digirad Delivers Letter To PDI, Inc. Responding To PDI's Summary Rejection Of Digirad's Offer To Acquire Company 3Digirad Delivers Letter To PDI, Inc. Responding To PDI's Summary Rejection Of Digirad's Offer To Acquire Company 4Digirad Delivers Letter To PDI, Inc. Responding To PDI's Summary Rejection Of Digirad's Offer To Acquire Company 510th Anniversary Orthopaedic Foundation Gala Set For Success 2Specialised Therapeutics Australia Announces Breakthrough Cancer Drug Abraxane(R) to be PBS Listed for Metastatic Pancreatic Cancer 2Specialised Therapeutics Australia Announces Breakthrough Cancer Drug Abraxane(R) to be PBS Listed for Metastatic Pancreatic Cancer 3Specialised Therapeutics Australia Announces Breakthrough Cancer Drug Abraxane(R) to be PBS Listed for Metastatic Pancreatic Cancer 4Specialised Therapeutics Australia Announces Breakthrough Cancer Drug Abraxane(R) to be PBS Listed for Metastatic Pancreatic Cancer 5Specialised Therapeutics Australia Announces Breakthrough Cancer Drug Abraxane(R) to be PBS Listed for Metastatic Pancreatic Cancer 6Specialised Therapeutics Australia Announces Breakthrough Cancer Drug Abraxane(R) to be PBS Listed for Metastatic Pancreatic Cancer 7Specialised Therapeutics Australia Announces Breakthrough Cancer Drug Abraxane(R) to be PBS Listed for Metastatic Pancreatic Cancer 8
...
... The CoaguChek S System offers unparalleld ... just one minute requiring only 10 ... you to provide more comprehensive patient ... each patient. The CoaguChek S System ...
... The Instacup Multi-Drug Screen Panel is used for ... human urine. The Instacup Panel consists of a test ... the test card is inserted and the sample sealed ... It is not necessary to remove the test card ...
Detect LH surge for predicting ovulation, Able to detect as low as 40 mIU/mL LH or 30 mIU/mL LH, Simple, easy and accurate, Built-in control system...
Medicine Products: